Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?

The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Anesthesiology (Philadelphia) 1989-04, Vol.70 (4), p.667-671
Hauptverfasser: SCHWIEGER, I. M, HALL, R. I, SZIAM, F, HUG, C. C. JR
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 671
container_issue 4
container_start_page 667
container_title Anesthesiology (Philadelphia)
container_volume 70
creator SCHWIEGER, I. M
HALL, R. I
SZIAM, F
HUG, C. C. JR
description The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.
doi_str_mv 10.1097/00000542-198904000-00021
format Article
fullrecord <record><control><sourceid>pubmed_pasca</sourceid><recordid>TN_cdi_pubmed_primary_2494910</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2494910</sourcerecordid><originalsourceid>FETCH-LOGICAL-p235t-384ace1a215740b46c5ca38148bd28d1be556d690347816d83b362ab5d5b68493</originalsourceid><addsrcrecordid>eNo9T8lKA0EQbUSJMfoJQh-8jva-eJEQ3CDgRS9eQm-DLTM9w3TnEL_eHgwWFFWv3ntFFQAQo1uMtLxDc3BGGqyVRqyCpibBJ2CJOVENxpKfgmWd0YYiQs7BRc7fFUpO1QIsCNNMY7QEn-sUcvkKJToYUwmTcSUOKcOhhX305mfoTA9N8rANqZh06O5hzLA6pgCN25cAy9BVW3JzNxNwGOMQ_cMlOGtNl8PVsa7Ax9Pj--al2b49v27W22YklJeGKmZcwIZgLhmyTDjuDFWYKeuJ8tgGzoUXGlEmFRZeUUsFMZZ7boVimq7A9d_ecW_74HfjFHszHXbHHyt_c-RNdqZr51tj_pdJLJQmkv4CoOBhYg</addsrcrecordid><sourcetype>Index Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype></control><display><type>article</type><title>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</title><source>MEDLINE</source><source>Journals@Ovid Complete</source><source>EZB-FREE-00999 freely available EZB journals</source><creator>SCHWIEGER, I. M ; HALL, R. I ; SZIAM, F ; HUG, C. C. JR</creator><creatorcontrib>SCHWIEGER, I. M ; HALL, R. I ; SZIAM, F ; HUG, C. C. JR</creatorcontrib><description>The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.</description><identifier>ISSN: 0003-3022</identifier><identifier>EISSN: 1528-1175</identifier><identifier>DOI: 10.1097/00000542-198904000-00021</identifier><identifier>PMID: 2494910</identifier><identifier>CODEN: ANESAV</identifier><language>eng</language><publisher>Hagerstown, MD: Lippincott</publisher><subject>Anesthesia, Inhalation ; Anesthetics. Neuromuscular blocking agents ; Animals ; Biological and medical sciences ; Dogs ; Drug Interactions ; Enflurane ; Fentanyl - pharmacology ; Flumazenil - pharmacology ; Male ; Medical sciences ; Midazolam - pharmacology ; Naloxone - pharmacology ; Neuropharmacology ; Pharmacology. Drug treatments ; Pulmonary Alveoli ; Respiration</subject><ispartof>Anesthesiology (Philadelphia), 1989-04, Vol.70 (4), p.667-671</ispartof><rights>1989 INIST-CNRS</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><link.rule.ids>314,780,784,27924,27925</link.rule.ids><backlink>$$Uhttp://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&amp;idt=7168927$$DView record in Pascal Francis$$Hfree_for_read</backlink><backlink>$$Uhttps://www.ncbi.nlm.nih.gov/pubmed/2494910$$D View this record in MEDLINE/PubMed$$Hfree_for_read</backlink></links><search><creatorcontrib>SCHWIEGER, I. M</creatorcontrib><creatorcontrib>HALL, R. I</creatorcontrib><creatorcontrib>SZIAM, F</creatorcontrib><creatorcontrib>HUG, C. C. JR</creatorcontrib><title>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</title><title>Anesthesiology (Philadelphia)</title><addtitle>Anesthesiology</addtitle><description>The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.</description><subject>Anesthesia, Inhalation</subject><subject>Anesthetics. Neuromuscular blocking agents</subject><subject>Animals</subject><subject>Biological and medical sciences</subject><subject>Dogs</subject><subject>Drug Interactions</subject><subject>Enflurane</subject><subject>Fentanyl - pharmacology</subject><subject>Flumazenil - pharmacology</subject><subject>Male</subject><subject>Medical sciences</subject><subject>Midazolam - pharmacology</subject><subject>Naloxone - pharmacology</subject><subject>Neuropharmacology</subject><subject>Pharmacology. Drug treatments</subject><subject>Pulmonary Alveoli</subject><subject>Respiration</subject><issn>0003-3022</issn><issn>1528-1175</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>1989</creationdate><recordtype>article</recordtype><sourceid>EIF</sourceid><recordid>eNo9T8lKA0EQbUSJMfoJQh-8jva-eJEQ3CDgRS9eQm-DLTM9w3TnEL_eHgwWFFWv3ntFFQAQo1uMtLxDc3BGGqyVRqyCpibBJ2CJOVENxpKfgmWd0YYiQs7BRc7fFUpO1QIsCNNMY7QEn-sUcvkKJToYUwmTcSUOKcOhhX305mfoTA9N8rANqZh06O5hzLA6pgCN25cAy9BVW3JzNxNwGOMQ_cMlOGtNl8PVsa7Ax9Pj--al2b49v27W22YklJeGKmZcwIZgLhmyTDjuDFWYKeuJ8tgGzoUXGlEmFRZeUUsFMZZ7boVimq7A9d_ecW_74HfjFHszHXbHHyt_c-RNdqZr51tj_pdJLJQmkv4CoOBhYg</recordid><startdate>19890401</startdate><enddate>19890401</enddate><creator>SCHWIEGER, I. M</creator><creator>HALL, R. I</creator><creator>SZIAM, F</creator><creator>HUG, C. C. JR</creator><general>Lippincott</general><scope>IQODW</scope><scope>CGR</scope><scope>CUY</scope><scope>CVF</scope><scope>ECM</scope><scope>EIF</scope><scope>NPM</scope></search><sort><creationdate>19890401</creationdate><title>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</title><author>SCHWIEGER, I. M ; HALL, R. I ; SZIAM, F ; HUG, C. C. JR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-p235t-384ace1a215740b46c5ca38148bd28d1be556d690347816d83b362ab5d5b68493</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>1989</creationdate><topic>Anesthesia, Inhalation</topic><topic>Anesthetics. Neuromuscular blocking agents</topic><topic>Animals</topic><topic>Biological and medical sciences</topic><topic>Dogs</topic><topic>Drug Interactions</topic><topic>Enflurane</topic><topic>Fentanyl - pharmacology</topic><topic>Flumazenil - pharmacology</topic><topic>Male</topic><topic>Medical sciences</topic><topic>Midazolam - pharmacology</topic><topic>Naloxone - pharmacology</topic><topic>Neuropharmacology</topic><topic>Pharmacology. Drug treatments</topic><topic>Pulmonary Alveoli</topic><topic>Respiration</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>SCHWIEGER, I. M</creatorcontrib><creatorcontrib>HALL, R. I</creatorcontrib><creatorcontrib>SZIAM, F</creatorcontrib><creatorcontrib>HUG, C. C. JR</creatorcontrib><collection>Pascal-Francis</collection><collection>Medline</collection><collection>MEDLINE</collection><collection>MEDLINE (Ovid)</collection><collection>MEDLINE</collection><collection>MEDLINE</collection><collection>PubMed</collection><jtitle>Anesthesiology (Philadelphia)</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>SCHWIEGER, I. M</au><au>HALL, R. I</au><au>SZIAM, F</au><au>HUG, C. C. JR</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?</atitle><jtitle>Anesthesiology (Philadelphia)</jtitle><addtitle>Anesthesiology</addtitle><date>1989-04-01</date><risdate>1989</risdate><volume>70</volume><issue>4</issue><spage>667</spage><epage>671</epage><pages>667-671</pages><issn>0003-3022</issn><eissn>1528-1175</eissn><coden>ANESAV</coden><abstract>The anesthetic effects and interactions of midazolam and fentanyl were determined in terms of their reduction of enflurane MAC in dogs, and the effects of their specific antagonists were also investigated. Control enflurane MAC was determined by the tail clamp method in 18 mongrel dogs. Each animal then received an iv loading dose of midazolam followed by a constant infusion at 9.6 micrograms.kg-1.min-1 designed to produce a stable enflurane MAC reduction of approximately 40%, and enflurane MAC was determined following a 60-min observation period during which time the midazolam concentration in plasma stabilized. Fentanyl was then administered in a series of three incremental loading doses (15, 30, and 225 micrograms/kg) and infusions (0.05, 0.2, and 3.2 micrograms.kg-1.min-1) designed to produce enflurane MAC reductions of 30%, 50%, and 65%, respectively. Enflurane MAC was again determined following a 60-min observation period for each new infusion. In nine dogs after the fourth determination of enflurane MAC, fentanyl was discontinued and 1 mg/kg naloxone was administered iv every 10 min until enflurane MAC was determined for the last time. In the other nine dogs, midazolam was discontinued and 1.5 mg/kg flumazenil (RO 15-1788) was administered and enflurane MAC determined for the last time. The midazolam concentration in plasma remained stable at 414 +/- 134 ng/ml throughout the study, and in the absence of fentanyl reduced enflurane MAC by 40 +/- 10% (mean +/- SD). The addition of fentanyl produced significant further reductions in enflurane MAC.</abstract><cop>Hagerstown, MD</cop><pub>Lippincott</pub><pmid>2494910</pmid><doi>10.1097/00000542-198904000-00021</doi><tpages>5</tpages></addata></record>
fulltext fulltext
identifier ISSN: 0003-3022
ispartof Anesthesiology (Philadelphia), 1989-04, Vol.70 (4), p.667-671
issn 0003-3022
1528-1175
language eng
recordid cdi_pubmed_primary_2494910
source MEDLINE; Journals@Ovid Complete; EZB-FREE-00999 freely available EZB journals
subjects Anesthesia, Inhalation
Anesthetics. Neuromuscular blocking agents
Animals
Biological and medical sciences
Dogs
Drug Interactions
Enflurane
Fentanyl - pharmacology
Flumazenil - pharmacology
Male
Medical sciences
Midazolam - pharmacology
Naloxone - pharmacology
Neuropharmacology
Pharmacology. Drug treatments
Pulmonary Alveoli
Respiration
title Anesthetic interactions of midazolam and fentanyl: is there acute tolerance to the opioid?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2024-12-30T22%3A46%3A55IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-pubmed_pasca&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=Anesthetic%20interactions%20of%20midazolam%20and%20fentanyl:%20is%20there%20acute%20tolerance%20to%20the%20opioid?&rft.jtitle=Anesthesiology%20(Philadelphia)&rft.au=SCHWIEGER,%20I.%20M&rft.date=1989-04-01&rft.volume=70&rft.issue=4&rft.spage=667&rft.epage=671&rft.pages=667-671&rft.issn=0003-3022&rft.eissn=1528-1175&rft.coden=ANESAV&rft_id=info:doi/10.1097/00000542-198904000-00021&rft_dat=%3Cpubmed_pasca%3E2494910%3C/pubmed_pasca%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/2494910&rfr_iscdi=true